Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Warner Music Group has announced a $1.2 billion joint venture with Bain Capital, with the companies targeting high-profile catalog acquisitions.

Warner Music Group and Bain Capital are launching a joint venture to allow for the purchase of up to $1.2 billion in music catalogs.

SYDNEY—With businesses sending workers home at the start of the Covid-19 pandemic, Bain Capital’s Mike Murphy dashed to buy his first webcam. While browsing an electronics store, his phone ...

Bain Capital and Warner Music launch JV to invest $1.2bn in music catalogs The partnership was formed through equal equity commitments from WMG and Bain Capital.

American private investment firm Bain Capital is on the verge of acquiring a significant stake in Manappuram Finance, one of Kerala’s leading gold loan providers, in a deal valued at ...

The purchase of the whole Chili Peppers catalog marks a re-entry into the music industry for Bain Capital.

The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.